Prostate Cancer - Results from #28040

EAU 2011 - Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results of a matched-controlled multi-institutional analysis - Session Highli May 11, 2011

EAU 2011 - Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality? - Session Highlights May 11, 2011

EAU 2011 - Prostate cancer associated up-regulation of AMACR, EZH2 and PSMA correlates with diminished expression of specific microRNAs - Session Highlights May 11, 2011

EAU 2011 - Androstenedione is the most efficient precursor of intraprostatic testosterone production in primary human prostate cancer tissue - Session Highlights May 11, 2011

EAU 2011 - Health-related quality of life after salvage high intensity focused ultrasound treatment (HIFU) for locally radiorecurrent prostate cancer - Session Highlights May 11, 2011

EAU 2011 - A preoperative serum biomarker panel to identify patients with prostate cancer at high risk of biochemical recurrence following radical prostatectomy - Session Highlights May 11, 2011

EAU 2011 - Serum levels of pro-inflammatory cytokines immediately increase two days after application of docetaxel in patients with castration-resistant prostate cancer and correlate with apoptosis and clinical response - Session Highlights May 11, 2011

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation - Abstract May 10, 2011

Use of complementary and alternative medicine among men with prostate cancer in a rural setting - Abstract May 10, 2011

Physicians' attitudes about shared decision making for prostate cancer screening - Abstract May 10, 2011

Evaluation of image-guidance strategies with helical tomotherapy for localised prostate cancer - Abstract May 10, 2011

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 Study - Abstract May 10, 2011

The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer - Abstract May 10, 2011

Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis - Abstract May 10, 2011

Current status of pelvic lymph node dissection in prostate cancer: The New York PLND nomogram - Abstract May 10, 2011

Adjuvant radiation treatment after prostatectomy. Where do we stand? - Abstract May 10, 2011

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin - Abstract May 10, 2011

EAU 2011 - Vas deferens suspension improves early urine continence after RALP: A randomized analysis - Session Highlights May 10, 2011

EAU 2011 - Pathologic stage at prostatectomy over time: Has there been a trend toward intervention for localized disease in the robotic era? - Session Highlights May 10, 2011

EAU 2011 - Radical prostatectomy in men with continuous oral aspirin medication: Revisiting old paradigm? - Session Highlights May 10, 2011

Page 1403 of 1437